NCT00329095已完成4 期
An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures
Robin, Alan L., M.D.0 个研究点目标入组 60 人开始时间: 2005年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 主要终点
- Compliance.
研究概览
简要总结
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.
详细描述
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Currently using one or two topical ocular hypotensive medications
排除标准
- •Hypersensitivity to any component of medication
结局指标
主要结局
Compliance.
次要结局
未报告次要终点
研究者
相似试验
已完成
4 期
Evaluation of Hyperemia With the Use of Ocular Prostaglandin AnaloguesOpen Angle GlaucomaOcular HypertensionNCT00539526Allergan106
已完成
1 期
Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®GlaucomaNCT03966365Laboratorios Sophia S.A de C.V.24
Unknown
4 期
Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag IsopropylPrimary Open-angle GlaucomaNormal Tension GlaucomaGlaucoma, SuspectOcular HypertensionNCT05279716Santen Pharmaceutical Asia Pte. Ltd.150
已完成
4 期
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.GlaucomaOcular HypertensionNCT00143208Pfizer's Upjohn has merged with Mylan to form Viatris Inc.250
招募中
不适用
Efficacy of timolol in arresting progression in KeratoconusCTRI/2017/09/009859I120